Making New Drugs With a Dose of Artificial Intelligence
By CADE METZ from NYT Technology https://www.nytimes.com/2019/02/05/technology/artificial-intelligence-drug-research-deepmind.html?partner=IFTTT Technology Researchers at DeepMind, owned by Google’s parent company, and other companies are applying their powerful A.I. systems to drug discovery research. The New York Times https://www.nytimes.com/2019/02/05/technology/artificial-intelligence-drug-research-deepmind.html?partner=IFTTT
0 comments:
Post a Comment